Skip to main content
Log in

The effect of p66shc protein on the resistance of the RKO colon cancer cell line to oxidative stress

  • Molecular Biology of the Cell
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

P66shc protein is an alternative transcript product of the SHC1 gene. Whereas two other isoforms (p52shc and p46shc) have adaptor function in the RAS signaling pathway, p66shc regulates the amount of reactive oxygen species (ROS) in a cell. Previously, it was demonstrated that the p66shc genome knockout significantly extends maximal lifespan in mice. P66shc could translocate into the mitochondria and increase intracellular ROS level, although basic mechanisms of this activity remain poorly understood. P66shc seems to play a significant role in carcinogenesis since an increased expression of p66shc correlates with poor prognosis in colorectal carcinoma. In our study, we applied RNA interference using lentiviral constructions that express short hairpin RNA (shRNA) against the N-terminal CH2 domain of the p66shc isoform. As a consequence, the p66shc but not p52shc and p46shc isoforms was selectelively suppressed in the RKO colon carcinoma cell line. We found that RKO cells with p66shc knockdown have been shown to be more resistant to oxidative stress induced by hydrogen peroxide exposure or serum starvation. Moreover, mitochondrial fragmentation that depends on the mitochondrial ROS amount was significantly decreased in p66shc-deficient RKO cells. Our findings are consistent with the hypothesis that p66shc participates in mitochondrial accumulation of ROS during oxidative stress and consequently promotes induction of apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ROS:

Reactive oxygen species

GAPDH:

glyceraldehyde 3-phosphate dehydrogenase

Grb2:

growth factor receptor-bound protein

DCF-DA:

dichlorofluorescein diacetate

e3b1:

eps8 SH3 domain-binding protein

eps8:

epidermal growth factor receptor kinase substrate 8

MAPK:

mitogen-activated protein kinases

MnSOD:

manganese superoxide dismutase

Rac-1:

ras-related C3 botulinum toxin substrate 1

REF-1:

redox factor 1

shRNA:

small hairpin RNA

SOS1:

son of sevenless homolog 1

References

  1. Luzi L., Confalonieri S., Di Fiore P.P., Pelicci P.G. 2000. Evolution of Shc functions from nematode to human. Curr. Opin. Genet. Dev. 10, 668–674.

    Article  PubMed  CAS  Google Scholar 

  2. Migliaccio E., Mele S., Salcini A.E., et al. 1997. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 16, 706–716.

    Article  PubMed  CAS  Google Scholar 

  3. Giorgio M., Migliaccio E., Orsini F., et al. 2005. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 122, 221–233.

    Article  PubMed  CAS  Google Scholar 

  4. Migliaccio E., Giorgio M., Mele S., et al. 1999. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 402, 309–313.

    Article  PubMed  CAS  Google Scholar 

  5. Trinei M., Giorgio M., Cicalese A., et al. 2002. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA, and oxidative stress-induced apoptosis. Oncogene. 21, 3872–3878.

    Article  PubMed  CAS  Google Scholar 

  6. Orsini F., Moroni M., Contursi C., et al. 2006. Regulatory effects of the mitochondrial energetic status on mitochondrial p66Shc. Biol. Chem. 387, 1405–1410.

    Article  PubMed  CAS  Google Scholar 

  7. Pinton P., Rimessi A., Marchi S., et al. 2007. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science. 315, 659–663.

    Article  PubMed  CAS  Google Scholar 

  8. Khanday F.A., Santhanam L., Kasuno K., et al. 2006. Sos-mediated activation of rac1 by p66shc. J. Cell. Biol. 172, 817–822.

    Article  PubMed  CAS  Google Scholar 

  9. Abo A., Pick E., Hall A., et al. 1991. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature. 353, 668–670.

    Article  PubMed  CAS  Google Scholar 

  10. Radisky D.C., Levy D.D., Littlepage L.E., et al. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 436, 123–127.

    Article  PubMed  CAS  Google Scholar 

  11. Werner E., Werb Z. 2002. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J. Cell Biol. 158, 357–368.

    Article  PubMed  CAS  Google Scholar 

  12. Kuroda J., Ago T., Matsushima S., et al. 2010. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. U.S.A. 107, 15565–15570.

    Article  PubMed  CAS  Google Scholar 

  13. Ago T., Kuroda J., Pain J., et al. 2010. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ. Res. 106, 1253–1264.

    Article  PubMed  CAS  Google Scholar 

  14. Block K., Gorin Y., Abboud H.E. 2009. Subcellular localization of Nox4 and regulation in diabetes. Proc. Natl. Acad. Sci. U.S.A. 106, 14385–14390.

    Article  PubMed  CAS  Google Scholar 

  15. Borkowska A., Sielicka-Dudzin A., Herman-Antosiewicz A., et al. 2011. P66Shc mediated ferritin degradation-A novel mechanism of ROS formation. Free Radic. Biol. Med. 51, 658–663.

    Article  PubMed  CAS  Google Scholar 

  16. Wu Z., Rogers B., Kachi S., et al. 2006. Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina. J. Cell Physiol. 209, 996–1005.

    Article  PubMed  CAS  Google Scholar 

  17. Haga S., Terui K., Fukai M., et al. 2008. Preventing hypoxia/reoxygenation damage to hepatocytes by p66(shc) ablation: Up-regulation of anti-oxidant and anti-apoptotic proteins. J. Hepatol. 48, 422–432.

    Article  PubMed  CAS  Google Scholar 

  18. Koch O.R., Fusco S., Ranieri S.C., et al. 2008. Role of the life span determinant P66(shcA) in ethanol-induced liver damage. Lab. Invest. 88, 750–760.

    Article  PubMed  CAS  Google Scholar 

  19. Francia P., delli Gatti C., Bachschmid M., et al. 2004. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation. 110, 2889–2895.

    Article  PubMed  CAS  Google Scholar 

  20. Orsini F., Migliaccio E., Moroni M., et al. 2004. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J. Biol. Chem. 279, 25689–25695.

    Article  PubMed  CAS  Google Scholar 

  21. Camici G.G., Schiavoni M., Francia P., et al. 2007. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc. Natl. Acad. Sci. USA. 104, 5217–5222.

    Article  PubMed  CAS  Google Scholar 

  22. Sansone P., Storci G., Giovannini C., et al. 2007. p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells. 25, 807–815.

    Article  PubMed  CAS  Google Scholar 

  23. Grossman S.R., Lyle S., Resnick M.B., et al. 2007. p66 Shc tumor levels show a strong prognostic correlation with disease outcome in stage IIA colon cancer. Clin. Cancer Res. 13, 5798–5804.

    Article  PubMed  CAS  Google Scholar 

  24. Lane D.P. 1992. Cancer: p53, guardian of the genome. Nature. 358, 15–16.

    Article  PubMed  CAS  Google Scholar 

  25. Iacopetta B. 2003. TP53 mutation in colorectal cancer. Hum. Mutat. 21, 271–276.

    Article  PubMed  CAS  Google Scholar 

  26. Russo A., Corsale S., Cammareri P., et al. 2005. Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy. J. Cell Physiol. 204, 742–749.

    Article  PubMed  CAS  Google Scholar 

  27. Bashir M., Kirmani D., Bhat H.F., et al. 2010. P66shc and its downstream Eps8 and Rac1 proteins are upregulated in esophageal cancers. Cell Commun. Signal. 8, 13.

    Article  PubMed  Google Scholar 

  28. Lee M.S., Igawa T., Chen S.J., et al. 2004. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas. Int. J. Cancer. 108, 672–678.

    Article  PubMed  CAS  Google Scholar 

  29. Veeramani S., Igawa T., Yuan T.C., et al. 2005. Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells. Oncogene. 24, 7203–7212.

    Article  PubMed  CAS  Google Scholar 

  30. Sablina A.A., Budanov A.V., Ilyinskaya G.V., et al. 2005. The antioxidant function of the p53 tumor suppressor. Nature Med. 11, 1306–1313.

    Article  PubMed  CAS  Google Scholar 

  31. Nemoto S., Finkel T. 2002. Redox regulation of fork-head proteins through a p66shc-dependent signaling pathway. Science. 295, 2450–2452.

    Article  PubMed  CAS  Google Scholar 

  32. Skulachev V.P., Antonenko Y.N., Cherepanov D.A., et al. 2010. Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim. Biophys. Acta. 1797, 878–889.

    Article  PubMed  CAS  Google Scholar 

  33. Izyumov D.S., Domnina L.V., Nepryakhina O.K., et al. 2010. Mitochondria as source of reactive oxygen species under oxidative stress: Study with novel mitochondria-targeted antioxidants-the “Skulachev-ion” derivatives. Biochemistry (Moscow). 75, 123–129.

    Article  CAS  Google Scholar 

  34. Skulachev V.P., Anisimov V.N., Antonenko Y.N., et al. 2009. An attempt to prevent senescence: A mitochondrial approach. Biochim. Biophys. Acta. 1787, 437–461.

    Article  PubMed  CAS  Google Scholar 

  35. Chernyak B.V., Izyumov D.S., Lyamzaev K.G., et al. 2006. Production of reactive oxygen species in mitochondria of HeLa cells under oxidative stress. Biochim. Biophys. Acta. 1757, 525–534.

    Article  PubMed  CAS  Google Scholar 

  36. Zhuge J., Cederbaum A.I. 2006. Serum deprivation-induced HepG2 cell death is potentiated by CYP2E1. Free Radic. Biol. Med. 40, 63–74.

    Article  PubMed  CAS  Google Scholar 

  37. Pandey S., Lopez C., Jammu A. 2003. Oxidative stress and activation of proteasome protease during serum deprivation-induced apoptosis in rat hepatoma cells: Inhibition of cell death by melatonin. Apoptosis. 8, 497–508.

    Article  PubMed  CAS  Google Scholar 

  38. Satoh T., Sakai N., Enokido Y., et al. 1996. Survival factor-insensitive generation of reactive oxygen species induced by serum deprivation in neuronal cells. Brain Res. 733, 9–14.

    Article  PubMed  CAS  Google Scholar 

  39. Lee S.B., Kim J.J., Kim T.W., et al. 2010. Serum deprivation-induced reactive oxygen species production is mediated by Romo1. Apoptosis. 15, 204–218.

    Article  PubMed  CAS  Google Scholar 

  40. Skulachev V.P., Bakeeva L.E., Chernyak B.V., et al. 2004. Thread-grain transition of mitochondrial reticulum as a step of mitoptosis and apoptosis. Mol. Cell Biochem. 256-257, 341–358.

    Article  PubMed  Google Scholar 

  41. Bakeeva L.E., Chentsov Yu S., Skulachev V.P. 1978. Mitochondrial framework (reticulum mitochondriale) in rat diaphragm muscle. Biochim. Biophys. Acta. 501, 349–369.

    Article  PubMed  CAS  Google Scholar 

  42. Pletjushkina O.Y., Lyamzaev K.G., Popova E.N., et al. 2006. Effect of oxidative stress on dynamics of mitochondrial reticulum. Biochim. Biophys. Acta. 1757, 518–524.

    Article  PubMed  CAS  Google Scholar 

  43. Napoli C., Martin-Padura I., de Nigris F., et al. 2003. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc. Natl. Acad. Sci. U.S.A. 100, 2112–2116.

    Article  PubMed  CAS  Google Scholar 

  44. Smith W.W., Norton D.D., Gorospe M., et al. 2005. Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. J. Cell. Biol. 169, 331–339.

    Article  PubMed  CAS  Google Scholar 

  45. Menini S., Amadio L., Oddi G., et al. 2006. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes. 55, 1642–1650.

    Article  PubMed  CAS  Google Scholar 

  46. Tiberi L., Faisal A., Rossi M., et al. 2006. p66(Shc) gene has a pro-apoptotic role in human cell lines and it is activated by a p53-independent pathway. Biochem. Biophys. Res. Commun. 342, 503–508.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. R. Galimov.

Additional information

Original Russian Text © E.R. Galimov, A.S. Sidorenko, A.V. Tereshkova, O.Y. Pletyushkina, B.V. Chernyak, P.M. Chumakov, 2012, published in Molekulyarnaya Biologiya, 2012, Vol. 46, No. 1, pp. 139–146.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galimov, E.R., Sidorenko, A.S., Tereshkova, A.V. et al. The effect of p66shc protein on the resistance of the RKO colon cancer cell line to oxidative stress. Mol Biol 46, 126–133 (2012). https://doi.org/10.1134/S0026893312010062

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893312010062

Keywords

Navigation